XJ 106
Alternative Names: XJ-106Latest Information Update: 29 Sep 2023
At a glance
- Originator Starmab Biologics Shanghai
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Clostridium infections
Most Recent Events
- 08 Sep 2023 Early research in Clostridium infections in China (Unspecified) (Starmab Biologics Shanghai website, September 2023)